As Anthem (ANTM) Shares Declined, Shareholder Firefly Value Partners LP Has Cut Its Position; Cme Group (CME) Market Value Rose While Exane Derivatives Decreased Its Holding

May 24, 2018 - By Hazel Jackson

Anthem, Inc. (NYSE:ANTM) Logo

Ryan Heslop decreased its stake in Anthem Inc (ANTM) by 59.32% based on its latest 2017Q4 regulatory filing with the SEC. Firefly Value Partners Lp sold 94,800 shares as the company’s stock declined 2.73% with the market. The hedge fund run by Ryan Heslop held 65,000 shares of the health care company at the end of 2017Q4, valued at $14.63M, down from 159,800 at the end of the previous reported quarter. Firefly Value Partners Lp who had been investing in Anthem Inc for a number of months, seems to be less bullish one the $58.85 billion market cap company. The stock decreased 0.62% or $1.44 during the last trading session, reaching $230.62. About 671,251 shares traded. Anthem, Inc. (NYSE:ANTM) has risen 35.30% since May 24, 2017 and is uptrending. It has outperformed by 23.75% the S&P500.

Exane Derivatives decreased its stake in Cme Group (CME) by 11.98% based on its latest 2017Q4 regulatory filing with the SEC. Exane Derivatives sold 627 shares as the company’s stock rose 9.29% while stock markets declined. The institutional investor held 4,608 shares of the investment bankers and brokers and service company at the end of 2017Q4, valued at $672.78M, down from 5,235 at the end of the previous reported quarter. Exane Derivatives who had been investing in Cme Group for a number of months, seems to be less bullish one the $54.49B market cap company. The stock decreased 0.06% or $0.1 during the last trading session, reaching $160.01. About 1.11 million shares traded. CME Group Inc. (NASDAQ:CME) has risen 37.71% since May 24, 2017 and is uptrending. It has outperformed by 26.16% the S&P500.

Among 25 analysts covering Anthem Inc (NYSE:ANTM), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Anthem Inc had 81 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Anthem, Inc. (NYSE:ANTM) earned “Overweight” rating by JP Morgan on Thursday, April 26. On Friday, April 28 the stock rating was upgraded by Cantor Fitzgerald to “Overweight”. RBC Capital Markets maintained Anthem, Inc. (NYSE:ANTM) rating on Thursday, January 28. RBC Capital Markets has “Outperform” rating and $182 target. The rating was maintained by Jefferies on Wednesday, January 31 with “Buy”. The rating was upgraded by Wells Fargo on Tuesday, November 15 to “Outperform”. The rating was maintained by Credit Suisse with “Buy” on Thursday, February 1. The company was maintained on Thursday, July 30 by Oppenheimer. The firm has “Buy” rating given on Thursday, April 26 by J.P. Morgan. Jefferies maintained Anthem, Inc. (NYSE:ANTM) rating on Wednesday, October 25. Jefferies has “Hold” rating and $226.0 target. As per Thursday, February 1, the company rating was maintained by Morgan Stanley.

Firefly Value Partners Lp, which manages about $1.31 billion and $1.46B US Long portfolio, upped its stake in Powershares Qqq Trust Series 1 (Put) (QQQ) by 1.20M shares to 1.46M shares, valued at $227.02 million in 2017Q4, according to the filing. It also increased its holding in Noble Corp Plc (NYSE:NE) by 15.18M shares in the quarter, for a total of 15.58 million shares, and has risen its stake in Amazon.Com Inc (Put) (NASDAQ:AMZN).

More notable recent Anthem, Inc. (NYSE:ANTM) news were published by: Businesswire.com which released: “Anthem, Inc. to Acquire Aspire Health” on May 23, 2018, also Fool.com with their article: “These Companies Gave Bonuses or Raises After Tax Reform” published on May 24, 2018, Seekingalpha.com published: “Anthem (ANTM) Q1 2018 Results – Earnings Call Transcript” on April 25, 2018. More interesting news about Anthem, Inc. (NYSE:ANTM) were released by: Fortune.com and their article: “Term Sheet — Thursday, May 24” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “Anthem Inc.: Good Investment In The Healthcare Industry” with publication date: May 16, 2018.

Analysts await Anthem, Inc. (NYSE:ANTM) to report earnings on July, 25. They expect $4.16 earnings per share, up 23.44% or $0.79 from last year’s $3.37 per share. ANTM’s profit will be $1.06B for 13.86 P/E if the $4.16 EPS becomes a reality. After $5.41 actual earnings per share reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts -23.11% negative EPS growth.

More news for CME Group Inc. (NASDAQ:CME) were recently published by: Fool.com, which released: “CME Group (CME) Q1 2018 Earnings Conference Call Transcript” on April 27, 2018. Seekingalpha.com‘s article titled: “CME: Great Business, But Grossly Overvalued” and published on May 08, 2018 is yet another important article.

Analysts await CME Group Inc. (NASDAQ:CME) to report earnings on August, 7. They expect $1.68 earnings per share, up 36.59% or $0.45 from last year’s $1.23 per share. CME’s profit will be $572.06 million for 23.81 P/E if the $1.68 EPS becomes a reality. After $1.86 actual earnings per share reported by CME Group Inc. for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Among 19 analysts covering CME Group (NASDAQ:CME), 11 have Buy rating, 1 Sell and 7 Hold. Therefore 58% are positive. CME Group had 64 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, July 10 with “Buy”. On Thursday, March 8 the stock rating was maintained by Bank of America with “Buy”. The rating was upgraded by Goldman Sachs on Wednesday, February 7 to “Buy”. Jefferies maintained CME Group Inc. (NASDAQ:CME) on Friday, March 9 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 16. The stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given on Friday, January 8 by Deutsche Bank. The rating was maintained by Credit Suisse on Wednesday, January 6 with “Neutral”. The firm has “Hold” rating by Keefe Bruyette & Woods given on Friday, February 2. Barclays Capital maintained it with “Overweight” rating and $175 target in Friday, February 2 report. As per Tuesday, October 10, the company rating was maintained by Barclays Capital.

Since December 18, 2017, it had 0 insider buys, and 11 selling transactions for $10.30 million activity. 300 shares were sold by GEPSMAN MARTIN J, worth $49,287 on Thursday, February 15. The insider MELAMED LEO sold 7,300 shares worth $1.14M. The insider Pankau Ronald A. sold 200 shares worth $31,982. DUFFY TERRENCE A also sold $3.03 million worth of CME Group Inc. (NASDAQ:CME) shares. Shares for $539,452 were sold by Piell Hilda Harris. 3,815 CME Group Inc. (NASDAQ:CME) shares with value of $614,372 were sold by Bernacchi Jeffrey M..

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.14, from 1.01 in 2017Q3. It improved, as 29 investors sold CME shares while 224 reduced holdings. 78 funds opened positions while 212 raised stakes. 265.76 million shares or 0.05% less from 265.89 million shares in 2017Q3 were reported. Aperio Gp holds 206,340 shares. Veritable Ltd Partnership invested in 10,409 shares. Paradigm Asset Mgmt Ltd Liability, New York-based fund reported 450 shares. Kepos Limited Partnership owns 30,000 shares. 2,087 are held by Independence Trust. Pitcairn invested in 3,419 shares. Wells Fargo And Mn holds 0.18% or 4.22 million shares in its portfolio. Yhb Invest Inc, a Connecticut-based fund reported 26,210 shares. Susquehanna Gru Ltd Liability Partnership reported 62,648 shares. Quantbot Tech LP has 0.27% invested in CME Group Inc. (NASDAQ:CME) for 19,901 shares. Burns J W And Company New York has invested 0.67% of its portfolio in CME Group Inc. (NASDAQ:CME). Ariel Limited Liability Com reported 29,910 shares or 0.05% of all its holdings. Daiwa Sb Invs Ltd reported 150 shares. Moreover, Conning Incorporated has 0.08% invested in CME Group Inc. (NASDAQ:CME). Scotia Cap, a Ontario – Canada-based fund reported 2,917 shares.

CME Group Inc. (NASDAQ:CME) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Hazel Jackson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts